b'Guest: Jordan E. Axelrad, MD, MPH
\\n\\n\\n \\n
This activity will have a key focus on S1P receptor modulators that will address how to select optimal therapy for ulcerative colitis based on clinical trial data, guidelines, and shared decision-making. Tune in with Dr. Jordan Axelrad, Associate Professor of Gastroenterology at the NYU Grossman School of Medicine.
'